Zealand Pharma — Maj 2025
-
Er bunden nået for fedmeaktier? Det spørgsmål møder Helge Larsen meget disse dage. Og det er naturligt nok om den sektor, som har fået nogle ordentlige klø, men hvor det den seneste uges tid har set pænt ud. Han kigger på Zealand Pharma, Novo Nordisk, Eli Lilly og Gubra og ser frem mod deres regnskaber, som er lige om hjørnet. Kort video: https://proinvestor.com/boards/126139
-
-
En fin artikel om Roche/Zealand
-
Zealand Pharma får sænket kursmål men gentaget købsanbefaling hos Kempen https://proinvestor.com/investornyt/1312295/zealand-pharma-far-saenket-kursmal-men-gentaget-kobsanbefaling-hos-kempen
-
Zealand Pharma efter stort kursfald: "Obesity fatigue" kan simpelthen ikke være rigtigt https://proinvestor.com/investornyt/1314067/zealand-pharma-efter-stort-kursfald-obesity-fatigue-kan-simpelthen-ikke-vaere-rigtigt
-
Zealand-topchef kalder første kvartal for måske bedste nogensinde efter Roche-aftale https://proinvestor.com/investornyt/1314064/zealand-topchef-kalder-forste-kvartal-for-maske-bedste-nogensinde-efter-roche-aftale
-
Zealand Pharmas aftale med Roche løber med opmærksomheden i nyhedsfattigt regnskab https://proinvestor.com/investornyt/1314077/zealand-pharmas-aftale-med-roche-lober-med-opmaerksomheden-i-nyhedsfattigt-regnskab
-
Zealand Q1: Det går som planlagt, men 1 tal gør indtryk https://proinvestor.com/boards/126280
-
Endnu et rekordregnskab er kommet fra Novo Nordisk med en ventet nedjustering. Først reagerede markedet positivt, men torsdag røg kursen tilbage. Det dykker Helge Larsen ned i årsagerne til, og kigger fremad både for resten af 2025, men også mod 2030. Han kommer desuden kort ind på Zealand Pharma, Eli Lilly og Gubra. Kort video: https://proinvestor.com/boards/126286
-
Godmorgen
-
Zealand Pharma announces closing of collaboration and license agreement with Roche
Copenhagen, Denmark, May 9, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces that all closing conditions in the collaboration and license agreement with Roche announced on March 12, 2025 have been satisfied, including regulatory conditions, and the
-
agreement has become effective.
-
We are incredibly excited to launch this partnership, which represents a step change to realize Zealand Pharma’s vision of becoming a key player in the future management of obesity. Roche ticked all the right boxes for what we were looking for in a partner and we look very much forward to working closely together to unlock the full potential of petrelintide to benefit people who are overweight or obese”, said Adam Steensberg, Chief Executive Officer at Zealand Pharma.
-
Zealand Pharma får sænket sit kursmål til 780 kr. fra 850 kr. af svenske SEB https://proinvestor.com/investornyt/1314687/zealand-pharma-far-saenket-sit-kursmal-til-780-kr-fra-850-kr-af-svenske-seb
-
Zealands kursmål skåret 8 pct. af Goldcman Sachs https://proinvestor.com/investornyt/1314691/zealands-kursmal-skaret-8-pct-af-goldcman-sachs
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1314702/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Spørgsmål til Q&A er meget velkommen.
-
Novo Nordisk, Eli Lilly, life science: Derfor steg aktierne på trods af nye tiltag https://proinvestor.com/boards/126340
-
Novo og Zealand kan se GSK købe middel mod fedtlever for milliardbeløb https://proinvestor.com/investornyt/1316852/novo-og-zealand-kan-se-gsk-kobe-middel-mod-fedtlever-for-milliardbelob
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind